Working… Menu
Trial record 1 of 39 for:    fshd
Previous Study | Return to List | Next Study

Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) (FSHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04003974
Recruitment Status : Recruiting
First Posted : July 1, 2019
Last Update Posted : November 11, 2019
Information provided by (Responsible Party):
Fulcrum Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : August 2020